ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) is a blank-check company sponsored by ARYA Sciences Holdings IV, an affiliate of Perceptive Advisors, the New York-based healthcare-focused investment firm. The vehicle completed its initial public offering in 2021 and targets the life sciences and biotechnology sector, consistent with the broader ARYA Sciences SPAC family's strategy of backing clinical-stage and emerging healthcare companies. A Form 425 filing submitted to the SEC on July 26, 2024 indicates the company was engaged in an active business combination process. For complete filing history, deal timeline, and sponsor analytics on ARYD and hundreds of other active SPACs, create a free account at SpacDesk.